LF Canlife UK Equity Income B

An exchange traded fund seeking to deliver an income of at least 110% of the yield of the FTSE All-Share index.

  • 422.21p Price (Inc)
  • - Price (Acc)
  • 0.00% Initial charge
  • 1.50% Annual management charge
  • 1.18% Ongoing charges
  • 4.90% Yield

Prices as at 06 December 2019

Fund summary

Sector UK Equity Income
Structure OEIC
Launched September, 1983
Size £251m
Yield 4.90%
Charging basis Capital
Dividends paid 15 Apr, 15 Oct

Charges

Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 1.50%
Ongoing charges figure 1.18%

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Investment process

The fund aims to provide half-yearly income and some capital growth mainly form investment in UK quoted shares providing an above average yield.

Manager research

Average monthly relative returns

  • 14/15 0.92%
  • 15/16 -0.26%
  • 16/17 -0.04%
  • 17/18 -0.01%
  • 18/19 -0.34%

Bestinvest MRI

  • 3 years -0.13%
  • 5 years 0.06%
  • Career -0.02%
  • 3 years 44.00%
  • 5 years 81.30%
  • Career 87.70%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Craig Rippe

After graduating with a degree in Mathematics from Warwick University, Rippe joined Deloitte & Touche. He qualified there as a chartered accountant, specialising in the auditing and forensic investigation of financial institutions. He joined Govett Investment Management Limited in February 2001 as an Investment Analyst with a particular focus on UK Equity Income Products, and was appointed fund manager in July 2003.

Track record

Craig Rippe has 15.8 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been -0.02%. During the worst period of relative performance (from December 2006 - November 2011) there was a decline of 16% relative to the index. The worst absolute loss has been 32%.

Periods of worst performance

Absolute -32.00% (October 2007 - March 2009)
Relative -16.00% (December 2006 - November 2011)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Top 10 holdings

Data accurate as at 31 August 2019

6.6% Bp
5.3% Astrazeneca Plc
5.3% Glaxosmithkline
4.8% Royal Dutch Shell
4% Hsbc Hldgs
3.8% Bhp Group Ltd
3.1% British American Tobacco
3.1% Crh
3% Imperial Brands Plc
2.9% Bae Systems
Source: Trustnet

Sector breakdown

Financials 22.00%
Consumer Staples 15.00%
Materials 13.00%
Health Care 12.00%
Energy 11.00%
Industrials 11.00%
Utilities 7.00%
Others 6.00%
Communications 3.00%

Key Investor Information

Download